(Q39455969)

12 September 2017

title

Inhibition of poly(ADP-ribose) polymerase (PARP) induces apoptosis in lung cancer cell lines (English)

1 reference

12 September 2017

Nupur N Gangopadhyay

1

1 reference

12 September 2017

James D Luketich

2

1 reference

12 September 2017

Amy Opest

3

1 reference

12 September 2017

Carmen Visus

4

1 reference

12 September 2017

Ernest M Meyer

5

1 reference

12 September 2017

Rodney Landreneau

6

1 reference

12 September 2017

Matthew J Schuchert

7

1 reference

12 September 2017

publication date

1 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

29

1 reference

12 September 2017

issue

9

1 reference

12 September 2017

page(s)

608-616

1 reference

Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

The potential role and application of PARP inhibitors in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Synthetic lethality--a new direction in cancer-drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

ABT-888 confers broad in vivo activity in combination with temozolomide in diverse tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Inhibition of matrix metalloproteinase-2 by PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Poly(ADP-ribosyl)ation is implicated in the G0-G1 transition of resting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Disruption of the Fanconi anemia pathway in human cancer in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Caspases and caspase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

(ADP-ribose)n participates in DNA excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.621916

10.3109/07357907.2011.621916

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference